Longwood Fund
About
Longwood Fund Longwood Fund manages $650M+ in total AUM, with Fund VI closing at $180M as their largest fund to date. The track record is exceptional for biotech company creation: partners have co-founded approximately 25 companies with 20+ launched and marketed drugs and therapies. Portfolio companies include GRAIL, BridgeBio, and PTC Therapeutics, alongside clinical-stage assets, with 10 IPOs and 8 acquisitions across the portfolio. The company founding pedigree tells the real story. Longwood
Industries
Stage focus
Pre-SeedSeed
Geography
US
Notable investments
- GRAIL
- BridgeBio
- PTC Therapeutics
- Acceleron
- Alnylam
- Vertex
Raising from Longwood Fund?
I've worked with founders across the industrial stack. If Longwood Fund is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan